These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 21175165
1. Characterization of differences between blood sample matrices in untargeted metabolomics. Denery JR, Nunes AA, Dickerson TJ. Anal Chem; 2011 Feb 01; 83(3):1040-7. PubMed ID: 21175165 [Abstract] [Full Text] [Related]
2. UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant. Barri T, Dragsted LO. Anal Chim Acta; 2013 Mar 20; 768():118-28. PubMed ID: 23473258 [Abstract] [Full Text] [Related]
4. Applications of mass spectrometry in metabolomic studies of animal model and invertebrate systems. Kamleh MA, Dow JA, Watson DG. Brief Funct Genomic Proteomic; 2009 Jan 20; 8(1):28-48. PubMed ID: 19074496 [Abstract] [Full Text] [Related]
5. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard. Jemal M, Schuster A, Whigan DB. Rapid Commun Mass Spectrom; 2003 Jan 20; 17(15):1723-34. PubMed ID: 12872277 [Abstract] [Full Text] [Related]
8. Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Guo K, Li L. Anal Chem; 2009 May 15; 81(10):3919-32. PubMed ID: 19309105 [Abstract] [Full Text] [Related]
9. 13C isotope-labeled metabolomes allowing for improved compound annotation and relative quantification in liquid chromatography-mass spectrometry-based metabolomic research. Giavalisco P, Köhl K, Hummel J, Seiwert B, Willmitzer L. Anal Chem; 2009 Aug 01; 81(15):6546-51. PubMed ID: 19588932 [Abstract] [Full Text] [Related]
14. Sample preparation prior to the LC-MS-based metabolomics/metabonomics of blood-derived samples. Gika H, Theodoridis G. Bioanalysis; 2011 Jul 17; 3(14):1647-61. PubMed ID: 21756097 [Abstract] [Full Text] [Related]
15. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid. Prasad B, Singh S. J Pharm Biomed Anal; 2010 Jul 08; 52(3):377-83. PubMed ID: 19692195 [Abstract] [Full Text] [Related]
18. Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics. Nordström A, Want E, Northen T, Lehtiö J, Siuzdak G. Anal Chem; 2008 Jan 15; 80(2):421-9. PubMed ID: 18085752 [Abstract] [Full Text] [Related]
19. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer. An Z, Chen Y, Zhang R, Song Y, Sun J, He J, Bai J, Dong L, Zhan Q, Abliz Z. J Proteome Res; 2010 Aug 06; 9(8):4071-81. PubMed ID: 20560663 [Abstract] [Full Text] [Related]
20. Validating regulatory-compliant wide dynamic range bioanalytical assays using chip-based nanoelectrospray tandem mass spectrometry. Wickremsinhe ER, Ackermann BL, Chaudhary AK. Rapid Commun Mass Spectrom; 2005 Aug 06; 19(1):47-56. PubMed ID: 15570573 [Abstract] [Full Text] [Related] Page: [Next] [New Search]